Title : Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.

Pub. Date : 2009 Jul 1

PMID : 19291793






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells. Imatinib Mesylate tumor protein p53 Homo sapiens
2 As reported previously, p53(wild) CML was more resistant to imatinib than that lacking p53. Imatinib Mesylate tumor protein p53 Homo sapiens
3 Here, we searched for an imatinib-induced p53 independent proapoptotic mechanism. Imatinib Mesylate tumor protein p53 Homo sapiens
4 We found imatinib up-regulated phosphorylation of p38 mitogen-activated protein kinase (MAPK), checkpoint kinase 2 (chk2) and transactivation-competent (TA) p73; expression of pml and bax; formation of PML-nuclear body (NB); and co-localization of TAp73/PML-NB in p53-nonfunctioning K562 and p53(mutant) Meg-01 CML cells, but not in BCR-ABL(-) HL60 cells. Imatinib Mesylate tumor protein p53 Homo sapiens
5 We found imatinib up-regulated phosphorylation of p38 mitogen-activated protein kinase (MAPK), checkpoint kinase 2 (chk2) and transactivation-competent (TA) p73; expression of pml and bax; formation of PML-nuclear body (NB); and co-localization of TAp73/PML-NB in p53-nonfunctioning K562 and p53(mutant) Meg-01 CML cells, but not in BCR-ABL(-) HL60 cells. Imatinib Mesylate tumor protein p53 Homo sapiens
6 The imatinib-induced co-localization was also found in primary CML cells from 3 of 6 patients, including 2 with p53(mutant) and one with p53(wild). Imatinib Mesylate tumor protein p53 Homo sapiens
7 The imatinib-induced co-localization was also found in primary CML cells from 3 of 6 patients, including 2 with p53(mutant) and one with p53(wild). Imatinib Mesylate tumor protein p53 Homo sapiens
8 A novel p53-independent proapoptotic mechanism using p38 MAPK /pml/TAp73 axis with a step processing at PML-NB and probably with chk2 and bax being involved is hereby evident in some imatinib-treated CML cells. Imatinib Mesylate tumor protein p53 Homo sapiens